Form 4 for ORGO Organogenesis Holdings Inc.
Accepted 2025-03-12 00:00:00 ET · period of report 2025-03-09 · accession 0001062993-25-005250 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-12 | 2025-03-09 | ORGO | Cavorsi Robert | VP, Strategy | F - Tax | $5.16 | -271 | 189.5K | -0.1% | -$1,398 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-03-09 | F | D | 210 | $5.16 | 189,586 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-03-09 | F | D | 61 | $5.16 | 189,525 | D | — | — |